Canada’s Cannabis Industry Unites to Create the Cannabis Canada Council: Names New Board and Appoints Executive Director
OTTAWA, April 23, 2018 /CNW/ – The Cannabis Canada Association (CCA), Canadian Medical Cannabis Council (CMCC), as well as Canopy Growth Corporation, have joined together to create a single national industry association for the sector, to be called the Cannabis Canada Council (“Cannabis Canada” or “C3”).
To govern the unified organisation, the general membership has elected the following individuals to the Board of Directors:
Dr. Avtar Dhillon – Emerald Health Therapeutics, Board Chair
John Fowler – The Supreme Cannabis Company, Vice Chair, Adult Use
Philippe Lucas – Tilray, Vice Chair, Medical
Cam Battley – Aurora Cannabis Inc.
Allison Gordon – 48 North Cannabis Co.
Jeff Jacobson – Cronos Group
Darren Karasiuk – MedReleaf
Megan McCrae – Aphria
Jeff Ryan – Canopy Growth Corporation
John Stewart – Emblem Cannabis
Sebastien St-Louis – Hydropothecary
Neil Closner – MedReleaf (ex officio)
To ensure that the needs of both Canada’s medical cannabis patients and the emerging adult consumer use market are addressed, Cannabis Canada has also amended its governance structure to include two primary committees, each led by a Vice Chair, which will focus on the needs of medical patients and adult consumer use clients respectively.
To support the Board, Cannabis Canada has also appointed Allan Rewak as the Executive Director.
“I am honoured to have been elected as Chair of the Cannabis Canada Council by my peers. We as a board will lead a united sector forward during a historically significant time, as one mutually supportive team. Together we will realize our shared goals of ensuring fair access for patients, successful and comprehensive legalization of adult use, building a robust legal and regulated industry, and keeping cannabis away from underage youth.”
Dr. Avtar Dhillon (Emerald Health Therapeutics), Board Chair
“The unification of Canada’s cannabis industry into one organisation will streamline and strengthen our ability to advocate on behalf of our members, patients and stakeholders, and to work effectively with all levels of government.”
Philippe Lucas (Tilray), Vice Chair (Medical)
“The Cannabis Canada Council will speak on behalf of our members with respect to both the adult consumer use and medical segments. The governance structure that we have adopted will allow us the flexibility to do this, ensuring that the opportunities and innovations of the consumer market are harnessed, while also guaranteeing that medical patients remain a priority.”
John Fowler, (Supreme Cannabis), Vice Chair (Adult Use)
“I am honoured and humbled to have been chosen as the Executive Director of C3. The legal Cannabis sector offers unparalleled economic and social opportunity for Canadians and the Cannabis Canada Council is ready to lead the way to a brighter future for all citizens of this incredible country.”
Allan Rewak, Executive Director
About the Cannabis Canada Council
C3 is the trade association of Canada’s Licensed Producers of Medical Cannabis under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR).
The Council’s mission is to act as the national voice for our members in their promotion of industry standards; support the development, growth and integrity of the regulated cannabis industry; and serve as an important resource on issues related to the safe and responsible use of cannabis for medical and non-medical purposes.
Members of the Cannabis Canada Council share a philosophy of both patient-centric care and improved public health, and are committed to product safety and quality, secure and reliable access, and the promotion of the safe and healthful use of cannabis.
For further information: Allan Rewak, Executive Director, Cannabis Canada Council, Allan.Rewak@cann-can.ca, (647) 206-1231,